CareDx (CDNA) Tops Q1 EPS by 44c ; Offers Guidance

CareDx (NASDAQ: CDNA) reported Q1 EPS of ($0.03), $0.44 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $72 million versus the consensus estimate of $63.48 million.

GUIDANCE:

CareDx sees FY2024 revenue of $274-282 million, versus the consensus of $267 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Halozyme prices $1.3B convertible notes offering due 2033
• Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss of $0.75/sh